–Recently announced positive Phase 1 topline safety, pharmacokinetic (“PK”) and pharmacodynamic (“PD”) data show that intravenous (“IV”)...
Listing fees linked to the recent reverse takeover were significant. The post Safe Supply Posts Q4 Uplisting Costs Ahead of New Game Plan appeared first...
2023— the year that everyone in the psychedelic industry prepared for takeoff. Well, theoretical (but probable) take off. And, just a few weeks before...
Highlights: Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid...
Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development...
New Jersey lawmakers were able to legalize cannabis and now they have their sights set on psychedelics. Legislature sponsored by state senator Nicholas...
Q1 Fiscal 2024 Highlights All financial results are reported in Canadian dollars unless otherwise stated. VANCOUVER, BC, Jan. 15, 2024 /CNW/ – Numinus...
Q1 Fiscal 2024 Highlights All financial results are reported in Canadian dollars unless otherwise stated. VANCOUVER, BC, Jan. 15, 2024 /CNW/ – Numinus...
Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the...
Psyence Group Inc. (CSE: PSYG) reported that its subsidiary, Psyence Biomedical Ltd. issued four senior secured convertible notes to raise $10 million....